UFP INDUSTRIES INC
For the period ended Dec 27, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
UFPI$80.79-2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| (in thousands of United States dollars) · · Year Ended | |||||||||
| · · December 27, · · December 28, · · December 30, | |||||||||
| · · 2025 · · 2024 · · 2023 | |||||||||
| Cash flows from operating activities: | | | | | | | | | |
| Net earnings | | $295,992 | | $418,733 | | $514,457 | |||
| Adjustments to reconcile net earnings to net cash from operating activities: | | | | | | | | | |
| Depreciation | | 138,360 | | | 124,641 | | 110,563 | ||
| Amortization of intangibles | | 22,691 | | | 23,521 | | 21,327 | ||
| Expense associated with share-based and grant compensation arrangements | | 37,792 | | | 38,163 | | 34,899 | ||
| Deferred income taxes | | 49,915 | | | (15,382) | | (5,573) | ||
| Unrealized gain on investments and other | | (2,431) | | | (1,217) | | (2,435) | ||
| Impairment of investments | | | 6,500 | | | — | | | — |
| Equity in (earnings) loss of investee | | | (709) | | | (89) | | | 2,367 |
| Net loss (gain) loss on sale, disposition and impairment of assets | | 728 | | | 678 | | (260) | ||
| Impairment of goodwill and other intangibles | | | 2,400 | | | 5,479 | | | — |
| Gain from reduction of estimated earnout liability | | | (2,312) | | | (2,460) | | | (3,177) |
| Changes in: | | | | | | | | | |
| Accounts receivable | | 27,464 | | | 47,070 | | 81,659 | ||
| Inventories | | 7,291 | | | 6,356 | | 250,561 | ||
| Accounts payable and cash overdraft | | (20,190) | | | 22,394 | | (3,578) | ||
| Accrued liabilities and other | | (17,754) | | | (25,316) | | (40,920) | ||
| Net cash from operating activities | | 545,737 | | 642,571 | | 959,890 | |||
| Cash flows used in investing activities: | | | | | | | | | |
| Capital expenditures | | (269,377) | | | (232,274) | | (180,382) | ||
| Proceeds from sale of property, plant and equipment | | 31,472 | | | 11,501 | | 3,291 | ||
| Acquisitions and purchases of noncontrolling interest, net of cash received | | (17,626) | | | (29,830) | | (52,383) | ||
| Purchases of investments | | (38,767) | | | (55,397) | | (29,806) | ||
| Proceeds from sale of investments | | 19,953 | | | 30,844 | | 29,935 | ||
| Other | | 1,104 | | | 4,406 | | (10,819) | ||
| Net cash used in investing activities | | (273,241) | | (270,750) | | (240,164) | |||
| Cash flows used in financing activities: | | | | | | | | | |
| Borrowings under revolving credit facilities | | 34,426 | | | 29,913 | | 28,462 | ||
| Repayments under revolving credit facilities | | (38,133) | | | (32,256) | | (30,125) | ||
| Repayments of debt | | | — | | | (40,000) | | | (29) |
| Repayment of debt on behalf of investee | | | — | | | (6,303) | | | — |
| Contingent consideration payments and other | | | (221) | | | (4,868) | | | (6,262) |
| Proceeds from issuance of common stock | | 2,471 | | | 2,811 | | 2,750 | ||
| Dividends paid to shareholders | | (82,350) | | | (80,782) | | (68,238) | ||
| Distributions to noncontrolling interest | | | (3,005) | | | (11,848) | | | (7,355) |
| Purchase of remaining noncontrolling interest of subsidiary | | | (549) | | | (4,902) | | | — |
| Payments to taxing authorities in connection with shares directly withheld from employees | | | (9,591) | | | (17,838) | | | — |
| Repurchase of common stock | | (433,028) | | | (141,120) | | (82,149) | ||
| Other | | (163) | | | 73 | | 86 | ||
| Net cash used in financing activities | | (530,143) | | (307,120) | | (162,860) | |||
| Effect of exchange rate changes on cash | | 3,124 | | | (7,363) | | 5,767 | ||
| Net change in cash and cash equivalents | | (254,523) | | 57,338 | | 562,633 | |||
| Cash, cash equivalents, and restricted cash, beginning of period | | 1,179,594 | | 1,122,256 | | 559,623 | |||
| Cash, cash equivalents, and restricted cash, end of period | | $925,071 | | $1,179,594 | | $1,122,256 | |||
| Reconciliation of cash, cash equivalents, and restricted cash: | | | | | | | | | |
| Cash and cash equivalents, beginning of period | | $1,171,828 | | $1,118,329 | | $559,397 | |||
| Restricted cash, beginning of period | | | 7,766 | | | 3,927 | | | 226 |
| Cash, cash equivalents, and restricted cash, beginning of period | | $1,179,594 | | $1,122,256 | | $559,623 | |||
| Cash and cash equivalents, end of period | | $914,199 | | $1,171,828 | | $1,118,329 | |||
| Restricted cash, end of period | | | 10,872 | | | 7,766 | | | 3,927 |
| Cash, cash equivalents, and restricted cash, end of period | | $925,071 | | $1,179,594 | | $1,122,256 | |||
| Supplemental information: | | | | | | | | | |
| Interest paid | | $10,910 | | $12,762 | | $12,736 | |||
| Income taxes paid | | 63,719 | | 128,115 | | 158,145 | |||
| Non-cash investing activities: | | | | | | | | | |
| Capital expenditures included in accounts payable | | $703 | | $3,485 | | $3,178 | |||
| Non-cash financing activities: | | | | | | | | | |
| Common stock issued under deferred compensation plans | | $12,029 | | $11,920 | | $10,978 | |||
See notes to consolidated financial statements
UFP INDUSTRIES, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.